Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden

• Elham Hedayati ,

  Roles Methodology, Writing – original draft, Writing – review & editing

  * E-mail: Elham.hedayati@ki.se

  Affiliations Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, Breast Cancer Flow, Patient Area of Breast Cancer Sarcoma and Endocrine Tumors, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden

  http://orcid.org/0000-0003-1352-4332

  ⨯
• Lionel Fracheboud,

  Roles Methodology, Writing – original draft, Writing – review & editing

  Affiliation The Boston Consulting Group AG, Zurich, Switzerland

  ⨯
• Vaidyanathan Srikant,

  Roles Conceptualization, Supervision

  Affiliation The Boston Consulting Group AG, Zurich, Switzerland

  ⨯
• David Greber,

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  Affiliation The Boston Consulting Group AG, Zurich, Switzerland

  ⨯
• Susanne Wallberg,

  Roles Methodology

  Affiliation Breast Cancer Flow, Patient Area of Breast Cancer Sarcoma and Endocrine Tumors, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Christina Linder Stragliotto

  Roles Methodology, Writing – original draft, Writing – review & editing

  Affiliations Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, Breast Cancer Flow, Patient Area of Breast Cancer Sarcoma and Endocrine Tumors, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden

  ⨯